Artelo Biosciences closes $3M public offering of common stock and pre-funded warrants

ARTELO BIOSCIENCES, INC.

Closed underwritten offering of 640,924 shares at $4.40/share and 40,894 pre-funded warrants at $4.399 each.
Gross proceeds of ~$3.0 million; underwriter has 45-day option for an additional 102,272 shares.
Net proceeds to advance preclinical/clinical development of product candidates and for working capital.
R.F. Lafferty & Co. acted as sole book-running manager; offering closed on September 5, 2025.

item 1.01item 7.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.